Form 4: Zimmer Biomet Director Betsy Bernard Reports Transactions

Betsy J. Bernard, a Director at Zimmer Biomet Holdings, Inc., reported transactions involving phantom stock units and restricted stock units.

Summary

• Director Betsy J. Bernard of Zimmer Biomet Holdings, Inc. has reported transactions related to her beneficial ownership of company securities.
• These transactions involve phantom stock units and restricted stock units, which are forms of equity compensation.
• The phantom stock units were accrued under the company's Deferred Compensation Plan for Non-Employee Directors.
• The restricted stock units reported are immediately vested but subject to mandatory deferral.
• The reporting person's address is listed as 345 E. MAIN STREET, WARSAW INDIANA 46580.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents routine insider transactions and does not contain new financial performance data or strategic shifts.

Positives

• Director Bernard's restricted stock units are immediately 100% vested, indicating a current ownership stake.
• The transactions reflect ongoing participation and commitment from a key member of the board.

Risks

• The restricted stock units are subject to mandatory deferral until termination of service as a Director or three years after the grant date, which could limit immediate liquidity for the reporting person.
• The phantom stock units are settled in shares within sixty days after cessation of service as a Director, also indicating a deferred settlement.

Future Outlook

The filing does not contain forward-looking statements or guidance. It solely reports on past transactions and current beneficial ownership.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions in the medical device industry, providing transparency on executive and director holdings. This filing indicates continued equity-based compensation for directors at Zimmer Biomet.

Stakeholder Impact

• Shareholders gain insight into a director's equity holdings and compensation structure.
• Employees may observe the company's compensation practices for its board members.

Next Steps

• Settlement of phantom stock units within sixty days after cessation of service as a Director.
• Mandatory deferral of restricted stock units until termination of service as a Director or three years after the grant date.

Key Dates

Keywords

Zimmer Biomet Holdings, ZBH, Form 4, Insider Trading, Director Compensation, Phantom Stock Units, Restricted Stock Units, Beneficial Ownership, SEC Filing